CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | July/August 2014

CoreValve: Assessing the Clinical Trials

A review of trial patient selection and results, as well as clinical implications.

By Steven J. Yakubov, MD, FACC, and Kyle Feldmann, MD

cit | Article | January/February 2013

Status of Left Atrial Appendage Closure

Interventional strategies developed to decrease stroke risk in patients with atrial fibrillation.

By Steven J. Yakubov, MD, FACC, FSCAI, and Jonathan Forquer, DO

cit | Article | September/October 2013

Percutaneous Suture Ligation for LAA Closure

Procedural overview and current data on left atrial appendage ligation with the Lariat device.

By Steven J. Yakubov, MD, FACC, FSCAI, and Connor B. Yakubov

cit | Article | May/June 2010

Does the Metal Matter?

An overview of next-generation stent platforms.

By Louis A. Cannon, MD, Fscai, FACC, FACP; Gary A. Daniel, MD; Kristin L. Hood, PHD; and Steven J. Yakubov, MD, FACC

Advertisement

Advertisement

cit | Article | March/April 2015

TAVR in Intermediate-Risk Patients

What the results from ongoing randomized trials may tell us about expanding TAVR to lower-risk patients.

By Arash Arshi, MD, FACC; Daniel R. Watson, MD; and Steven J. Yakubov, MD, FACC

cit | Article | September/October 2016

Managing the Risk of Coronary Occlusion During TAVR

Effective planning for valve retrieval and coronary protection is essential.

By Carlos E. Sanchez, MD, FACC, FSCAI; Arash Arshi, MD, FACC, FSCAI; and Steven J. Yakubov, MD, FACC, FSCAI

cit | Article | September/October 2022

Three-Dimensional Intracardiac Echocardiography Use in Tricuspid Valve Edge-to-Edge Repair

Technologies and techniques for optimal image guidance in TV TEER.

By Carlos E. Sanchez, MD, and Steven J. Yakubov, MD

cit | Article | January/February 2017

Bleeding Avoidance Strategies

Experts offer their experience with acute coronary syndrome protocol and how they approach access sites and handle bleeding events.

With Andrey Espinoza, MD, FACC, FSCAI; Paul A. Gurbel, MD; Sunil V. Rao, MD; and Steven J. Yakubov, MD, FACC, FSCAI

cit | Article | March/April 2019

Roundtable Discussion: TAVR in Low-Risk Patients

Experts discuss the significance of recent data and the potential impact on their practice.

With Kentaro Hayashida, MD, PhD, FESC, FACC, FJCS; Robert Ostfeld, MD, MSc, FACC; Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; Michael J. Reardon, MD; and Steven J. Yakubov, MD, FACC, FSCAI

cit | Article | July/August 2014

Transcatheter Heart Valve Landscape

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | September/October 2022

Contemporary Mitral & Tricuspid Therapies

By Gagan D. Singh, MD, and Azeem Latib, MD

cit | Article | March/April 2019

Perspectives in TAVR

By Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC, and Samir Kapadia, MD, FACC, FSCAI

cit | Article | May/June 2010

Advances in DES Technology

By Ted E. Feldman, MD, FSCAI

cit | Article | September/October 2013

Valvular Interventions

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | March/April 2015

THV Expansion

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | January/February 2013

Chief Medial Editor's Page

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | News | November 27, 2024

Medtronic’s Evolut TAVR Device Assessed in Results From OPTIMIZE PRO and EVOLUT PRO Studies

November 27, 2024—Medtronic announced new data for the Evolut transcatheter aortic valve replacement (TAVR) system in the treatment of patients with symptomatic severe aortic stenosis (AS).

cit | Article | September/October 2016

Radial Update

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | News | August 15, 2019

FDA Approves Low-Risk Indication for TAVR

August 16, 2019—The FDA announced it has approved an expanded indication for transcatheter aortic valve replacement devices to include patients with severe aortic valve stenosis who are at low risk for death or major complications associated with open heart surgery to replace the damaged valves.

Sponsored by BioTrace Medical Inc.

cit | Article | March/April 2018

Rethinking the Temporary Pacing Lead

The Tempo® Lead from BioTrace Medical Inc. delivers safe lead placement, secure pace capture, and postprocedure ambulation.


1
2

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button